226 related articles for article (PubMed ID: 9684874)
1. Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4.
Fitzpatrick VD; Pisacane PI; Vandlen RL; Sliwkowski MX
FEBS Lett; 1998 Jul; 431(1):102-6. PubMed ID: 9684874
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.
Sliwkowski MX; Schaefer G; Akita RW; Lofgren JA; Fitzpatrick VD; Nuijens A; Fendly BM; Cerione RA; Vandlen RL; Carraway KL
J Biol Chem; 1994 May; 269(20):14661-5. PubMed ID: 7514177
[TBL] [Abstract][Full Text] [Related]
3. Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells.
Fiddes RJ; Janes PW; Sanderson GM; Sivertsen SP; Sutherland RL; Daly RJ
Cell Growth Differ; 1995 Dec; 6(12):1567-77. PubMed ID: 9019162
[TBL] [Abstract][Full Text] [Related]
4. A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.
Lee H; Akita RW; Sliwkowski MX; Maihle NJ
Cancer Res; 2001 Jun; 61(11):4467-73. PubMed ID: 11389077
[TBL] [Abstract][Full Text] [Related]
5. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.
Schaefer G; Fitzpatrick VD; Sliwkowski MX
Oncogene; 1997 Sep; 15(12):1385-94. PubMed ID: 9333014
[TBL] [Abstract][Full Text] [Related]
6. Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage display.
Ballinger MD; Jones JT; Lofgren JA; Fairbrother WJ; Akita RW; Sliwkowski MX; Wells JA
J Biol Chem; 1998 May; 273(19):11675-84. PubMed ID: 9565588
[TBL] [Abstract][Full Text] [Related]
7. Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness.
Lewis GD; Lofgren JA; McMurtrey AE; Nuijens A; Fendly BM; Bauer KD; Sliwkowski MX
Cancer Res; 1996 Mar; 56(6):1457-65. PubMed ID: 8640840
[TBL] [Abstract][Full Text] [Related]
8. Binding interaction of the heregulinbeta egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesis.
Jones JT; Ballinger MD; Pisacane PI; Lofgren JA; Fitzpatrick VD; Fairbrother WJ; Wells JA; Sliwkowski MX
J Biol Chem; 1998 May; 273(19):11667-74. PubMed ID: 9565587
[TBL] [Abstract][Full Text] [Related]
9. Receptor binding and biological activity of mammalian expressed sensory and motor neuron-derived factor (SMDF).
Osheroff PL; Tsai SP; Chiang NY; King KL; Li R; Lewis GD; Wong K; Henzel W; Mather J
Growth Factors; 1999; 16(3):241-53. PubMed ID: 10372964
[TBL] [Abstract][Full Text] [Related]
10. Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3.
Carraway KL; Soltoff SP; Diamonti AJ; Cantley LC
J Biol Chem; 1995 Mar; 270(13):7111-6. PubMed ID: 7535767
[TBL] [Abstract][Full Text] [Related]
11. Insulin regulates heregulin binding and ErbB3 expression in rat hepatocytes.
Carver RS; Sliwkowski MX; Sitaric S; Russell WE
J Biol Chem; 1996 Jun; 271(23):13491-6. PubMed ID: 8662847
[TBL] [Abstract][Full Text] [Related]
12. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
Feroz K; Williams E; Riese DJ
Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
[TBL] [Abstract][Full Text] [Related]
13. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.
Bourguignon LY; Gilad E; Peyrollier K
J Biol Chem; 2007 Jul; 282(27):19426-41. PubMed ID: 17493932
[TBL] [Abstract][Full Text] [Related]
14. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.
Li Z; Mei Y; Liu X; Zhou M
Cell Signal; 2007 Mar; 19(3):466-71. PubMed ID: 16978839
[TBL] [Abstract][Full Text] [Related]
15. The structural basis for the specificity of epidermal growth factor and heregulin binding.
Barbacci EG; Guarino BC; Stroh JG; Singleton DH; Rosnack KJ; Moyer JD; Andrews GC
J Biol Chem; 1995 Apr; 270(16):9585-9. PubMed ID: 7721889
[TBL] [Abstract][Full Text] [Related]
16. ErbB3 and ErbB2/neu mediate the effect of heregulin on acetylcholine receptor gene expression in muscle: differential expression at the endplate.
Altiok N; Bessereau JL; Changeux JP
EMBO J; 1995 Sep; 14(17):4258-66. PubMed ID: 7556067
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity and specificity of directed toxins composed of diphtheria toxin and the EGF-like domain of heregulin beta1.
Landgraf R; Pegram M; Slamon DJ; Eisenberg D
Biochemistry; 1998 Mar; 37(9):3220-8. PubMed ID: 9485477
[TBL] [Abstract][Full Text] [Related]
18. Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase.
Tan M; Grijalva R; Yu D
Cancer Res; 1999 Apr; 59(7):1620-5. PubMed ID: 10197638
[TBL] [Abstract][Full Text] [Related]
19. Mutation of a Shc binding site tyrosine residue in ErbB3/HER3 blocks heregulin-dependent activation of mitogen-activated protein kinase.
Vijapurkar U; Cheng K; Koland JG
J Biol Chem; 1998 Aug; 273(33):20996-1002. PubMed ID: 9694850
[TBL] [Abstract][Full Text] [Related]
20. Changes in heregulin beta1 (HRGbeta1) signaling after inhibition of ErbB-2 expression in a human breast cancer cell line.
Yoo JY; Hamburger AW
Mol Cell Endocrinol; 1998 Mar; 138(1-2):163-71. PubMed ID: 9685225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
